RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Rockefeller Capital Management L.P.'s Holding History (CIK: 0001739439)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 34,289 Value ($000) $140 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 53,434 Value ($000) $261 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 216,765 Value ($000) $1,097 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 387,456 Value ($000) $2,050 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 281,922 Value ($000) $1,906 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 66,639 Value ($000) $439 Avg Close $7.17 Range $5.88 - $8.73
Q1 2024
Shares 21,246 Value ($000) $212 Avg Close $11.14 Range $8.68 - $15.74
Q4 2022
Shares 2,378 Value ($000) $0 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 7,319 Value ($000) $77 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 5,941 Value ($000) $48 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 12,588 Value ($000) $90 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 10,397 Value ($000) $178 Avg Close $18.82 Range $15.25 - $23.86
Q3 2021
Shares 2,050 Value ($000) $47 Avg Close $28.34 Range $17.80 - $42.81
Q2 2021
Shares 1,000 Value ($000) $36 Avg Close $29.60 Range $19.68 - $38.39